Automated Immunoassay Analyzers Market to surpass $25 billion by 2024: Global Market Insights, Inc.
June 21, 2017 06:30 ET
|
Global Market Insights, Inc
Ocean View, Delaware, June 21, 2017 (GLOBE NEWSWIRE) -- The Industry Share report “Automated Immunoassay Analyzers Market Size By Product (Immunofluorescence, Chemiluminescence, ELISA, Enzyme...
Stellar Biotechnologies to Present at the Second Annual Marcum LLP Microcap Conference
May 21, 2013 09:33 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - May 21, 2013) - Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that Frank Oaks, President & CEO and Darrell Brookstein,...
Stellar Biotechnologies Announces Preclinical Poster at Society of Toxicology (SOT) Showing That Forms and Sources of KLH Matter
March 13, 2013 09:10 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Mar 13, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of results from a...
Stellar Biotechnologies Exceeds Aquaculture Capacity Goals
February 19, 2013 08:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Feb 19, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company exceeded its 2012 plan...
Stellar Biotechnologies, Inc. to Host Conference Call at 2:30 pm ET on Tuesday, December 18, 2012 to Provide Business Overview
December 12, 2012 09:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Dec 12, 2012) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leader in sustainable...
Stellar Biotechnologies Engages MZ Group as Its Investor Relations Firm
October 23, 2012 07:00 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Oct 23, 2012) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leader in sustainable...
Stellar Biotechnologies Launches KLH Site(TM)
April 25, 2012 10:47 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Apr 25, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) announced today the launch of KLH Site™ at...
Stellar Biotechnologies Announces Exclusive Option to License Clostridium Difficile Technology
April 10, 2012 09:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Apr 10, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) today announced that it has entered into an...
Stellar Biotechnologies Launches Stellar KLH(TM) ELISA Test Kits
April 03, 2012 09:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Apr 3, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leader in sustainable manufacture of...
Stellar Biotechnologies Publishes New Corporate Profile
March 13, 2012 09:00 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Mar 13, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) announced today that the Company has published an...